Key facts
- This page summarizes Robert Philibert's Form 4 filing for Cardio Diagnostics Holdings, Inc. (CDIO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 21 Feb 2024, 15:06.
Robert Philibert - 23 Jan 2024 Form 4 Insider Report for Cardio Diagnostics Holdings, Inc. (CDIO)
- Reporting relationship
- Chief Medical Officer, Director
- Issuer ticker
- CDIO
- Reported as of
- 23 Jan 2024
- Net transaction value
- +$301,468
- SEC form
- 4
- Accepted by SEC
- 21 Feb 2024, 15:06:52 UTC
- Prior SEC filing
- 05 Sep 2023
- Next SEC filing
- 10 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Elisa Luqman as attorney-in-fact for Robert Philibert
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Philibert filed Form 4 for Cardio Diagnostics Holdings, Inc. (CDIO) on 21 Feb 2024.
Change
- Previous filing in this sequence was filed on 05 Sep 2023.
- Current net transaction value: +$301,468.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDIO
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $301,468
- Shares
- +142,876
- Change %
- +22%
- Price
- $2.11
- Shares after
- 805,465
- Date
- 23 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 142,876
- Exercise price
- $2.11
* marks a reported price that did not pass the local price check.